SCHEMBL13837919

SCHEMBL13837919

Cc1ccc(N(COCC[Si](C)(C)C)C(=O)c2cccc(C(C)(C)N)c2)cc1-n1c(=O)n(C)c2ccccc21

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.32
▸ EPHB4 P54760 1/20 0.31
▸ HDAC8 Q9BY41 2/20 0.31
▸ HDAC11 Q96DB2 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ BAZ2B Q9UIF8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16195352 0.90 BRAF (0.33) —
SCHEMBL13837918 0.80 HDAC8 (0.36) HDAC8HDAC11HDAC6
SCHEMBL13838150 0.76 GRM4 (0.35) EPHB4
SCHEMBL13837940 0.72 EPHB4 (0.51) EPHB4
SCHEMBL16195058 0.70 BRAF (0.38) HDAC8HDAC11HDAC6
SCHEMBL16195229 0.68 BRAF (0.35) —
SCHEMBL16194905 0.61 BRAF (0.54) —
SCHEMBL31211967 0.57 NPC1 (0.48) NPC1
SCHEMBL24405807 0.55 NPC1 (0.39) NPC1
SCHEMBL24405997 0.54 MAPT (0.39) NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012148792-A1 HETEROCYCLIC COMPOUNDS AS B-RAF INHIBITORS FOR TREATMENT OF CANCER MERCK SHARP & DOHME CORP. (US) 2012-11-01 — — WO disclosed
Send feedback